285 related articles for article (PubMed ID: 36080280)
1. Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions.
Stalmach A; Boehm I; Fernandes M; Rutter A; Skipworth RJE; Husi H
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080280
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive proteome analysis of human skeletal muscle in cachexia and sarcopenia: a pilot study.
Ebhardt HA; Degen S; Tadini V; Schilb A; Johns N; Greig CA; Fearon KCH; Aebersold R; Jacobi C
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):567-582. PubMed ID: 28296247
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
Evans WJ
Am J Clin Nutr; 2010 Apr; 91(4):1123S-1127S. PubMed ID: 20164314
[TBL] [Abstract][Full Text] [Related]
4. Loss of muscle mass: Current developments in cachexia and sarcopenia focused on biomarkers and treatment.
Drescher C; Konishi M; Ebner N; Springer J
Int J Cardiol; 2016 Jan; 202():766-72. PubMed ID: 26474466
[TBL] [Abstract][Full Text] [Related]
5. Integrated genomic and proteomic analyses identify stimulus-dependent molecular changes associated with distinct modes of skeletal muscle atrophy.
Hunt LC; Graca FA; Pagala V; Wang YD; Li Y; Yuan ZF; Fan Y; Labelle M; Peng J; Demontis F
Cell Rep; 2021 Nov; 37(6):109971. PubMed ID: 34758314
[TBL] [Abstract][Full Text] [Related]
6. Comparative plasma proteomics in muscle atrophy during cancer-cachexia and disuse: The search for atrokines.
Lim S; Dunlap KR; Rosa-Caldwell ME; Haynie WS; Jansen LT; Washington TA; Greene NP
Physiol Rep; 2020 Oct; 8(19):e14608. PubMed ID: 33063952
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle wasting after a severe burn is a consequence of cachexia and sarcopenia.
Song J; Clark A; Wade CE; Wolf SE
JPEN J Parenter Enteral Nutr; 2021 Nov; 45(8):1627-1633. PubMed ID: 34296448
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D, muscle recovery, sarcopenia, cachexia, and muscle atrophy.
Garcia M; Seelaender M; Sotiropoulos A; Coletti D; Lancha AH
Nutrition; 2019 Apr; 60():66-69. PubMed ID: 30529188
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview.
Ebner N; Elsner S; Springer J; von Haehling S
Curr Opin Support Palliat Care; 2014 Mar; 8(1):15-24. PubMed ID: 24452279
[TBL] [Abstract][Full Text] [Related]
10. Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia.
Yedigaryan L; Gatti M; Marini V; Maraldi T; Sampaolesi M
Cells; 2022 Jul; 11(15):. PubMed ID: 35892590
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Inflammation and Muscle Wasting in Aging and Disease.
Della Peruta C; Lozanoska-Ochser B; Renzini A; Moresi V; Sanchez Riera C; Bouché M; Coletti D
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902081
[TBL] [Abstract][Full Text] [Related]
12. Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting.
Nevi L; Pöllänen N; Penna F; Caretti G
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003594
[TBL] [Abstract][Full Text] [Related]
13. Plasma proteome profiling of healthy subjects undergoing bed rest reveals unloading-dependent changes linked to muscle atrophy.
Murgia M; Brocca L; Monti E; Franchi MV; Zwiebel M; Steigerwald S; Giacomello E; Sartori R; Zampieri S; Capovilla G; Gasparini M; Biolo G; Sandri M; Mann M; Narici MV
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):439-451. PubMed ID: 36517414
[TBL] [Abstract][Full Text] [Related]
14. Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Adv Gerontol; 2006; 18():39-54. PubMed ID: 16676797
[TBL] [Abstract][Full Text] [Related]
15. Muscle wasting: an overview of recent developments in basic research.
Palus S; von Haehling S; Springer J
Int J Cardiol; 2014 Oct; 176(3):640-4. PubMed ID: 25205489
[TBL] [Abstract][Full Text] [Related]
16. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
[TBL] [Abstract][Full Text] [Related]
17. Proteomic identification of biomarkers of skeletal muscle disorders.
Ohlendieck K
Biomark Med; 2013 Feb; 7(1):169-86. PubMed ID: 23387498
[TBL] [Abstract][Full Text] [Related]
18. Physiactisome: A New Nanovesicle Drug Containing Heat Shock Protein 60 for Treating Muscle Wasting and Cachexia.
Di Felice V; Barone R; Trovato E; D'Amico D; Macaluso F; Campanella C; Marino Gammazza A; Muccilli V; Cunsolo V; Cancemi P; Multhoff G; Coletti D; Adamo S; Farina F; Cappello F
Cells; 2022 Apr; 11(9):. PubMed ID: 35563712
[TBL] [Abstract][Full Text] [Related]
19. Cachexia and sarcopenia: mechanisms and potential targets for intervention.
Argilés JM; Busquets S; Stemmler B; López-Soriano FJ
Curr Opin Pharmacol; 2015 Jun; 22():100-6. PubMed ID: 25974750
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
Saitoh M; Ishida J; Doehner W; von Haehling S; Anker MS; Coats AJS; Anker SD; Springer J
Int J Cardiol; 2017 Jul; 238():5-11. PubMed ID: 28427849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
